The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on β-defensin 3

Journal of Investigative Dermatology

Volumn 127, Issue 10, 2007, Pages 2368-2380

  Kisich, Kevin O ^a,b   Howell, Michael D ^a   Boguniewicz, Mark ^a,b   Heizer, Heather R ^a   Watson, Nori U ^a   Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLCHICINE; N(G) NITROARGININE METHYL ESTER; POLYPEPTIDE ANTIBIOTIC AGENT; BETA DEFENSIN; BETA-DEFENSIN 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; KERATINOCYTE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRATUM CORNEUM; BIOPSY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; STAPHYLOCOCCUS INFECTION;

BETA-DEFENSINS; BIOPSY; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; KERATINOCYTES; RNA, MESSENGER; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34848918479     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700861     Document Type: Article

References (42)

1. Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG (2001) Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 117:106-11
2. Aufiero B, Duanmu Z, Guo M, Meduri NB, Murakawa GJ, Falkow S (2004) Staphylococcus aureus infection of human primary keratinocytes. J Dermatol Sci 38:173-5
3. Bayles KW, Wesson CA, Liou LE, Fox LK, Bohach GA, Trumble WR (1998) Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect Immun 66:336-42
4. Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 50:59-69
5. Bjerke JR, Tigalonova M, Matre R (1994) IgG-Fc receptors in stratum granulosum: an immunological defence in human skin? Acta Derm Venereol 74:429-32
6. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-71
7. Braff MH, Zaiou M, Fierer J, Nizet V, Gallo RL (2005) Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun 73:6771-81
8. Cauza K, Grassauer A, Hinterhuber G, Horvat R, Rappersberger K, Wolff K et al. (2002) FcgammaRIII expression on cultured human keratinocytes and upregulation by interferon-gamma. J Invest Dermatol 119:1074-9
9. Chung WO, Dale BA (2004) Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun 72:352-8
10. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V et al. (2001) Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus. J Invest Dermatol 117:91-7
11. Dovezenski N, Billetta R, Gigli I (1992) Expression and localization of proteins of the complement system in human skin. J Clin Invest 90:2000-12
12. Esche C, de Benedetto A, Beck LA (2004) Keratinocytes in atopic dermatitis: inflammatory signals. Curr Allergy Asthma Rep 4:276-84
13. Ezepchuk YV, Leung DY, Middleton MH, Bina P, Reiser R, Norris DA (1996) Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol 107:603-9
14. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA et al. (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436-44
15. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6:57-64
16. Gross GN, Rehm SR, Toews GB, Hart DA, Pierce AK (1978) Lung clearance of Staphylococcus aureus strains with differing protein A content: protein A effect on in vivo clearance. Infect Immun 21:7-9
17. Harder J, Bartels J, Christophers E, Schroder JM (1997) A peptide antibiotic from human skin. Nature 387:861
18. Harder J, Schroder JM (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 277:46779-84
19. Hunyadi J, Simon M Jr, Kenderessy AS, Dobozy A (1991) Expression of complement receptor CR2 (CD21) on human subcorneal keratinocytes in normal and diseased skin. Dermatologica 183:184-6
20. Janeway CA, Travers P, Walport M, Shlomchik M (eds). (2005) Immunobiology. New York: Garland Science
21. Kintarak S, Whawell SA, Speight PM, Packer S, Nair SP (2004) Internalization of Staphylococcus aureus by human keratinocytes. Infect Immun 72:5668-75
22. Kisich KO, Higgins M, Diamond G, Heifets L (2002) Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils. Infect Immun 70:4591-9
23. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505-20
24. Kroll C, Langner A, Borchert HH (1999) Nitroxide metabolism in the human keratinocyte cell line HaCaT. Free Radic Biol Med 26:850-7
25. Matsubara M, Harada D, Manabe H, Hasegawa K (2004) Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. FEBS Lett 566:195-200
26. Mempel M, Schnopp C, Hojka M, Fesq H, Weidinger S, Schaller M et al. (2002) Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol 146:943-51
27. Mempel M, Voelcker V, Kollisch G, Plank C, Rad R, Gerhard M et al. (2003) Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121:1389-96
28. Menzies BE, Kenoyer A (2005) Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides. Infect Immun 73:5241-4
29. Menzies BE, Kenoyer A (2006) Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes. Infect Immun 74:6847-54
30. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS et al. (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445-53
31. Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL (2004) Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 172:3070-7
32. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-9
33. Rennie RP, Jones RN, Mutnick AH (2003) Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diag Microbiol Infect Dis 45:287-93
34. Sala A, Zarini S, Folco G, Murphy RC, Henson PM (1999) Differential metabolism of exogenous and endogenous arachidonic acid in human neutrophils. J Biol Chem 274:28264-9
35. Scalettar BA, Swedlow JR, Sedat JW, Agard DA (1996) Dispersion, aberration and deconvolution in multi-wavelength fluorescence images. J Microsc 182:50-60
36. Sharlow ER, Paine CS, Babiarz L, Eisinger M, Shapiro S, Seiberg M (2000) The protease-activated receptor-2 upregulates keratinocyte phagocytosis. J Cell Sci 113:3093-101
37. Sorensen OE, Thapa DR, Roupe KM, Valore EV, Sjobring U, Roberts AA et al. (2006) Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 116:1878-85
38. Stanley JR, Yuspa SH (1983) Specific epidermal protein markers are modulated during calcium-induced terminal differentiation. J Cell Biol 96:1809-14
39. Tigalonowa M, Bjerke JR, Livden JK, Matre R (1990) The distribution of Fc gamma RI, Fc gamma RII and Fc gamma R III on Langerhans' cells and keratinocytes in normal skin. Acta Derm Venereol 70:385-90
40. Tokura Y, Yagi J, O'Malley M, Lewis JM, Takigawa M, Edelson RL et al. (1994) Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 102:31-8
41. Wehkamp K, Schwichtenberg L, Schroder JM, Harder J (2006) Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol 126:121-7
42. West MA, Bretscher MS, Watts C (1989) Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol 109:2731-9